LY4584180 / Eli Lilly - LARVOL DELTA

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers (clinicaltrials.gov) - P1 | N=360 | Not yet recruiting | Sponsor: Eli Lilly and Company

First-in-human • New P1 trial • Diffuse Large B Cell Lymphoma • Follicular Lymphoma • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology